Skip to main content

Table 3 Subgroup analysis: background characteristics and clinical outcomes of patients who are 75 years of age or older at the time of surgery

From: Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly

Age ≥75

 

N = 20

 

Gender n (%)

 

 Male

12 (60.0)

 Female

8 (40.0)

Age mean (range, SD)

76.7 (75–85)

Year of operation n (%)

 

 1996–2002

0

 2003–2007

6 (30.0)

 2008–2013

14 (70.0)

Diagnosis n (%)

 

 CRC (n = 184)

5 (25.0)

 PMP (n = 157)

6 (30.0)

 Mesothelioma (n = 53)

2 (10.0)

 Appendiceal cancer (n = 137)

6 (30.0)

 Others (n = 80)

1 (5.0)

HIPEC n (%)

9 (45.0)

EPIC n (%)

5 (25.0)

PCI mean (SD)

22.8 (13.0)

CC n (%)

 

 0

11 (55.0)

 1

5 (25.0)

 2

3 (15.0)

 3

0 (0)

Transfusion mean (SD)

5.2 (6.2)

Total hospital stay (days) median (range)

20.0 (9–157)

ICU stay (days) median (range)

2.0 (1–101)

HDU stay (days) median (range)

1.0 (0–20)

Hospital death n (%)

1 (5)

Complication grade n (%)

 

 0

5 (25.0)

 I

1 (5.0)

 II

4 (20.0)

 III

6 (30.0)

 IV

4 (20.0)

Tumour-related OS median (months) (95 %)

35.0 (17.3–52.7)

5-year OS (%)

18.6